Dexcom and Medtronic’s recent quarterly update calls shared new timing details on their latest continuous glucose monitoring (CGM) products – our team listens to all these calls and we wanted to give you a “what’s what!” update. Read below for specifics on the CGM upgrades, which will improve the experience of wearing CGM on many […]
JDRF and Sanofi have announced a $4.6 million, three-year initiative to expand development of insulins that require fewer injections and dermal patch-delivered insulin. In both cases, it’s hoped that the insulin delivered will be able to respond automatically to changes in blood sugar levels and other body metabolism signals.
People with both type 2 diabetes and obstructive sleep apnea (OSA) might not experience improved glycemic control when using continuous positive airway pressure (CPAP), according to new findings published by the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Anyone who has had to inject glucagon during a crisis would gladly reach for something easier to use, if it were available, but only if that alternative were just as effective in staving off hypoglycemia. Locemia Solutions has been developing an intranasal glucagon that offers the possibility of eliminating glucagon injections, and the company has […]
As with all type 1 diabetes cure research, a solution to the particular problem of encapsulation is elusive and still years (decades?) away. But despite the long timeline and the many hurdles still to be crossed before this material could potentially be used in a clinical setting, Vegas’s enthusiasm for the project is palpable.
The evidence that alcohol has any benefit on longevity or heart health is thin, says Dr. Timothy Naimi, a physician and epidemiologist at Boston Medical Center.
A recent study found that metformin might help overweight teens with Type 1 diabetes lower their A1C scores. Metformin, an oral medication that’s prescribed to treat Type 2 diabetes, helped the teens lower their insulin resistance.
According to a clinical perspective published in the Journal of the American College of Cardiology from the ACC Sports and Exercise Cardiology Leadership Council, people should be more alarmed by the impending harm from a lack of exercise than of any harm exercise may possibly cause.
Now researchers have come up with a simpler option – they’ve created a synthetic patch that’s covered in natural beta cells, which can be stuck painlessly to a patient’s skin to secrete insulin when it’s required and safely control blood sugar levels, no injection or monitoring required.
I had always hated math, but after weeks of constant carb counting, recording my blood glucose levels, and noting my insulin doses, I had numbers in my head all night. That made me anxious, and so did the fear of hypoglycemia. Sometimes early in the morning, my blood sugar would drop low, making me shaky […]
With diabetes, the stakes are high in the morning. A well-managed breakfast can dramatically improve my time in zone (70-140 mg/dl) for the rest of the day. Conversely, I might regret poor choices at breakfast three, five, even eight hours later.
Sleep-deprived people experience higher levels of a chemical that enhances the pleasurability of eating – particularly of foods that are sweet, salty or high in fat, researchers found. Even when participants had eaten 90 percent of their daily calories two hours before, they couldn’t resist “highly palatable, rewarding snacks” when faced with the opportunity to […]
While the trial found that weight loss of 10 or 15 percent was linked to even better outcomes, individuals struggling to shed pounds for health reasons may be able to start with smaller steps, the research revealed.
For patients with elevated HbA1c, the use of combination antihyperglycemic medications after inadequate control with metformin alone is commonly prescribed to help patients achieve individualized glycemic levels. Is there actual benefit in dual therapy treatment? Study looks at canagliflozin plus metformin.
The five-year study, called the “Insulin Resistance Intervention after Stroke” trial or “IRIS” trial, investigated the effect of pioglitazone on strokes and heart disease. The results? Compared to a placebo, pioglitazone led to a striking 24% reduction in fatal and non-fatal heart attacks and strokes. Moreover, the rate of new diabetes cases was reduced by […]
For context, this automated system controls blood glucose using CGM readings every five minutes, a mathematical algorithm, and pumps dosing insulin and glucagon. Right now the Bionic Pancreas is in the research phase, though the team has built an integrated system (iLet) expected to enter a pivotal trial in early 2017.
A natural plant pigment extract could be the ticket to creating “diabetic” bread, according to new research from the National University of Singapore.
Chris Schuh, 64, considers herself lucky to be alive. The Type 1 diabetes community can consider Schuh, who has enjoyed a decade without insulin injections after undergoing an experimental treatment, a symbol of hope.
The meeting provided the opportunity to hear from leading JDRF physicians and researchers about progress on everything from the artificial pancreas to islet cell replacement therapy to efforts in prevention. All in all, the two-day event was a remarkable opportunity to see firsthand how JDRF is driving progress in all areas of type 1 diabetes […]
A calcium-channel blocker drug that is normally used to treat high blood pressure may also be helpful in treating type 1 and type 2 diabetes, according to a new study from the University of Alabama.